Health Technology Aktx

Akari Therapeutics Plc

AKTX | $1.25 3.31% 3.2% 7.5K

(0.0% 1d) (-36.9% 1m) (526.3% 1y) (0.0% 2d) (-1.7% 3d) (1.7% 7d) (54.6% volume)
Earnings Calendar:
Market Cap: $ 9,904,620
http://akaritx.com
Sec Filling | Patents | 10 employees

(US) Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.

autoimmunity

add to watch list Paper trade email alert is off

Press-releases

Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
AKTX | $1.25 3.31% 3.2% 7.5K

Health Technology

| -6.3% | O: -3.15% H: 3.24% C: -2.44%
pre-clinical therapeutics

Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
Published: 2024-04-01 (Crawled : 11:00) - globenewswire.com
AKTX | $1.25 3.31% 3.2% 7.5K

Health Technology

| -33.15% | O: 3.93% H: 0.0% C: -18.38%
therapeutics financial results

Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to Contact Law Firm
Published: 2024-03-15 (Crawled : 17:00) - prnewswire.com
VIVK | $1.54 4.05% 3.9% 370K

Professional, Scientific, and T...

| 59.57% | O: -1.06% H: 1.06% C: -9.59%
MINM | $3.53 -0.28% -0.28% 29K

Manufacturing

| -50.07% | O: -4.56% H: 7.1% C: -7.68%
AKTX | $1.25 3.31% 3.2% 7.5K

Health Technology

| -41.67% | O: -1.23% H: 0.74% C: -2.23%
SDPI | $1.25 0.0% 38K

Industrial Services

| 39.14% | O: 0.18% H: 2.22% C: 2.12%

Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
Published: 2024-03-05 (Crawled : 13:00) - globenewswire.com
GERN | $3.57 2.0% 1.96% 6.6M

Health Technology

| 72.12% | O: 0.48% H: 4.55% C: 0.0%
AKTX | $1.25 3.31% 3.2% 7.5K

Health Technology

| -47.11% | O: 6.67% H: 0.0% C: -5.83%
drug antibody pipeline therapeutics agreement

Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing
Published: 2024-01-02 (Crawled : 13:00) - globenewswire.com
AKTX | $1.25 3.31% 3.2% 7.5K

Health Technology

| -61.86% | O: -1.28% H: 7.14% C: -5.95%
million therapeutics

Akari Therapeutics to Present at Biotech Showcase 2024
Published: 2023-12-14 (Crawled : 13:00) - globenewswire.com
AKTX | $1.25 3.31% 3.2% 7.5K

Health Technology

| -59.11% | O: 6.53% H: 3.23% C: -0.65%
biotech therapeutics

Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors
Published: 2023-12-01 (Crawled : 13:30) - akaritx.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -4.22% | O: 1.18% H: 0.0% C: 0.0%
AKTX | $1.25 3.31% 3.2% 7.5K

Health Technology

| -59.66% | O: -0.68% H: 15.13% C: 10.24%
life sciences therapeutics

Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference
Published: 2023-11-16 (Crawled : 13:00) - globenewswire.com
AKTX | $1.25 3.31% 3.2% 7.5K

Health Technology

| -62.46% | O: 9.78% H: 0.0% C: -7.18%
conference pre-clinical treatment therapeutics potential

Akari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference
Published: 2023-11-06 (Crawled : 13:00) - globenewswire.com
AKTX | $1.25 3.31% 3.2% 7.5K

Health Technology

| -67.04% | O: -0.28% H: 2.36% C: 2.36%
conference pre-clinical treatment therapeutics potential

Akari Therapeutics Reports First Half 2023 Financial Results and Highlights
Published: 2023-09-29 (Crawled : 12:00) - globenewswire.com
AKTX | $1.25 3.31% 3.2% 7.5K

Health Technology